NasdaqCM - Nasdaq Real Time Price • USD
Exicure, Inc. (XCUR)
At close: May 28 at 4:00 PM EDT
After hours: May 28 at 7:56 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Paul Kang | CEO & Director | -- | -- | 1962 |
| Ms. Jiyoung Hwang | CFO & Director | -- | -- | 1976 |
| Mr. Joshua Miller | Chief Accounting Officer | -- | -- | 1976 |
| Mr. Bart Anderson | Senior Director of R&D | -- | -- | -- |
Exicure, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 13
Description
Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Corporate Governance
Exicure, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 7; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
July 12, 2024 at 10:59 AM UTC - July 16, 2024 at 12:00 PM UTC
Exicure, Inc. Earnings Date
Recent Events
Related Tickers
SNSE Sensei Biotherapeutics, Inc.
0.8300
+5.06%
DBVT DBV Technologies S.A.
0.5944
-0.93%
SYBX Synlogic, Inc.
1.6200
+1.25%
KA Kineta, Inc.
0.4690
-1.30%
ZVSA ZyVersa Therapeutics, Inc.
4.2536
-2.89%
CERO CERo Therapeutics Holdings, Inc.
1.0600
+16.48%
CWBR CohBar, Inc.
0.7601
-13.62%
CLDI Calidi Biotherapeutics, Inc.
0.2591
+13.24%
SNTI Senti Biosciences, Inc.
0.3228
-5.09%
NRXS NeurAxis, Inc.
3.1600
0.00%